Global mental health and neuroscience: Potential synergies

The Lancet Psychiatry

Volumn 2, Issue 2, 2015, Pages 178-185

  Stein, Dan J ^a   He, Yanling ^b   Phillips, Anthony ^c   Sahakian, Barbara J ^d   Williams, John ^e   Patel, Vikram ^f  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SHANGHAI MENTAL HEALTH CENTER   (China)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MEDICAL ETHICS; MEDICAL SOCIETY; MENTAL DISEASE; MENTAL HEALTH CARE; PATHOGENESIS; PSYCHIATRIC DIAGNOSIS; REVIEW; RISK FACTOR; SOCIAL ENVIRONMENT; SOCIAL STATUS; TREATMENT INDICATION; GLOBAL HEALTH; MENTAL DISORDERS; NEUROSCIENCE;

GLOBAL HEALTH; HUMANS; MENTAL DISORDERS; NEUROSCIENCES;

EID: 84922822391     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(15)00014-0     Document Type: Review

References (54)

1. Tomlinson M, Rudan I, Saxena S, Swartz L, Tsai AC, Patel V Setting priorities for global mental health research. Bull World Health Organ 2009, 87:438-446.
2. Patel V Global mental health: from science to action. Harv Rev Psychiatry 2012, 20:6-12.
3. Frenk J, Chen L Overcoming gaps to advance global health equity: a symposium on new directions for research. Health Res Policy Syst 2011, 9:11.
4. Chisholm D, Sanderson K, Ayuso-Mateos JL, Saxena S Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry 2004, 184:393-403.
5. Dudley M, Silove D, Gale F Mental health and human rights: vision, praxis, and courage 2012, Oxford University Press, USA. 1st edn.
6. Akil H, Brenner S, Kandel E, et al. Medicine. The future of psychiatric research: genomes and neural circuits. Science 2010, 327:1580-1581.
7. Insel TR, Landis SC Twenty-five years of progress: the view from NIMH and NINDS. Neuron 2013, 80:561-567.
8. Insel TR, Quirion R Psychiatry as a clinical neuroscience discipline. JAMA 2005, 294:2221-2224.
9. Insel TR, Voon V, Nye JS, et al. Innovative solutions to novel drug development in mental health. Neurosci Biobehav Rev 2013, 37:2438-2444.
10. Schumann G, Binder EB, Holte A, et al. Stratified medicine for mental disorders. Eur Neuropsychopharmacol 2014, 24:5-50.
11. Collins PY, Patel V, Joestl SS, et al. Grand challenges in global mental health. Nature 2011, 475:27-30. the Scientific Advisory Board and the Executive Committee of the Grand Challenges on Global Mental Health.
12. Dua T, Barbui C, Clark N, et al. Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations. PLoS Med 2011, 8:e1001122.
13. A conceptual framework for the revision of the ICD-10 classification of mental and behavioural disorders. World Psychiatry 2011, 10:86-92. International Advisory Group for the Revision of ICD-10 Mental and Behavioural Disorders.
14. Insel T, Cuthbert B, Garvey M, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010, 167:748-751.
15. Cuthbert BN The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 2014, 13:28-35.
16. Hyman SE Can neuroscience be integrated into the DSM-V?. Nat Rev Neurosci 2007, 8:725-732.
17. Jacob KS, Patel V Classification of mental disorders: a global mental health perspective. Lancet 2014, 383:1433-1435.
18. Stein DJ, Lund C, Nesse RM Classification systems in psychiatry: diagnosis and global mental health in the era of DSM-5 and ICD-11. Curr Opin Psychiatry 2013, 26:493-497.
19. Owens M, Herbert J, Jones PB, et al. Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms. Proc Natl Acad Sci USA 2014, 111:3638-3643.
20. Wakefield JC, First MB Placing symptoms in context: the role of contextual criteria in reducing false positives in Diagnostic and Statistical Manual of Mental Disorders diagnoses. Compr Psychiatry 2012, 53:130-139.
21. Draft comprehensive mental health action plan 2013-2020 WHO. http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_10Rev1-en.pdf.
22. Closing the gap in a generation: Health equity through action on the social determinants of health WHO. http://www.who.int/social_determinants/publications/en/.
23. Insel TR, Landis SC, Collins FS Research priorities. Science 2013, 340:687-688. The NIH BRAIN Initiative.
24. Kendler KS Levels of explanation in psychiatric and substance use disorders: implications for the development of an etiologically based nosology. Mol Psychiatry 2012, 17:11-21.
25. Kendler KS Decision making in the pathway from genes to psychiatric and substance use disorders. Mol Psychiatry 2013, 18:640-645.
26. Caspi A, Moffitt TE Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 2006, 7:583-590.
27. Henrich J, Heine SJ, Norenzayan A The weirdest people in the world?. Behav Brain Sci 2010, 33:61-83. discussion 83-135.
28. Chiao JY, Hariri AR, Harada T, et al. Theory and methods in cultural neuroscience. Soc Cogn Affect Neurosci 2010, 5:356-361.
29. Barnett JH, Salmond CH, Jones PB, Sahakian BJ Cognitive reserve in neuropsychiatry. Psychol Med 2006, 36:1053-1064.
30. Hackman DA, Farah MJ Socioeconomic status and the developing brain. Trends Cogn Sci 2009, 13:65-73.
31. Rutter M, Dunn J, Plomin R, et al. Integrating nature and nurture: implications of person-environment correlations and interactions for developmental psychopathology. Dev Psychopathol 1997, 9:335-364.
32. van Os J, Krabbendam L, Myin-Germeys I, Delespaul P The schizophrenia envirome. Curr Opin Psychiatry 2005, 18:141-145.
33. Kleinman A Rethinking psychiatry: from cultural category to personal experience 1988, Free Press, New York.
34. Bronfenbrenner U Toward an experimental ecology of human development. Am Psychol 1977, 32:513-531.
35. Lund C, De Silva M, Plagerson S, et al. Poverty and mental disorders: breaking the cycle in low-income and middle-income countries. Lancet 2011, 378:1502-1514.
36. Susser M Does risk factor epidemiology put epidemiology at risk? Peering into the future. J Epidemiol Community Health 1998, 52:608-611.
37. Chisholm D, Flisher AJ, Lund C, et al. Scale up services for mental disorders: a call for action. Lancet 2007, 370:1241-1252. the Lancet Global Mental Health Group.
38. Nutt DJ, Attridge J CNS drug development in Europe--past progress and future challenges. Neurobiol Dis 2014, 61:6-20.
39. Insel TR, Sahakian BJ Drug research: a plan for mental illness. Nature 2012, 483:269.
40. Licinio J, Wong M-L Launching the 'war on mental illness'. Mol Psychiatry 2014, 19:1-5.
41. Nesse RM, Williams GC Why we get sick: The new science of Darwinian medicine 1994, Vintage Books, New York.
42. Nesse RM, Berridge KC Psychoactive drug use in evolutionary perspective. Science 1997, 278:63-66.
43. Cohen A, Gilman SE, Houck PR, Szanto K, Reynolds CF Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults. Soc Psychiatry Psychiatr Epidemiol 2009, 44:272-277.
44. Nemeroff CB, Heim CM, Thase ME, et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci USA 2003, 100:14293-14296.
45. Patel V Reducing the burden of depression in youth: what are the implications of neuroscience and genetics on policies and programs?. J Adolesc Health 2013, 52(suppl 2):S36-S38.
46. Walsh BT, Seidman SN, Sysko R, Gould M Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002, 287:1840-1847.
47. Patel V, Chowdhary N, Rahman A, Verdeli H Improving access to psychological treatments: lessons from developing countries. Behav Res Ther 2011, 49:523-528.
48. Sahakian BJ, Malloch G, Kennard C A UK strategy for mental health and wellbeing. Lancet 2010, 375:1854-1855. the Mental Health Review Group.
49. Sahakian BJ What do experts think we should do to achieve brain health?. Neurosci Biobehav Rev 2014, 43:240-258.
50. Sahakian BJ, Hyman SE Ethical considerations of neuroscience research and the application of neuroscience research findings for the Presidential Commission for the Study of Bioethical Issues. J Law Biosci 2014, 1:237-242.
51. Kendler KS Diagnostic approaches to schizotypal personality disorder: a historical perspective. Schizophr Bull 1985, 11:538-553.
52. Copeland JRM Use of Kraepelinian concepts in international computer diagnosis. Eur Arch Psychiatry Clin Neurosci 2008, 258(suppl 2):33-36.
53. Stein DJ, Harvey BH, Uys J, Daniels W Suffer the children: the psychobiology of early adversity. CNS Spectr 2005, 10:612-615.
54. Stein DJ The psychobiology of resilience. CNS Spectr 2009, 14(suppl 3):41-47.